Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice
- 2 June 2008
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 9 (9) , 1481-1494
- https://doi.org/10.1517/14656566.9.9.1481
Abstract
Background: Chronic lymphocytic leukaemia patients harbour important impairments in both their cellular- and humoral-mediated immunity, which accounts for their notorious susceptibility to a multitude of infections and various autoimmune cytopenias. It has also been shown that the rate of second cancers is increased in chronic lymphocytic leukaemia. Objective: The aim of this study was to review the immune alterations in untreated and treated chronic lymphocytic leukaemia and define their impact for clinical practice. Methods: The author gives a comprehensive review of the most relevant preclinical and clinical studies pertaining to various immune abnormalities and infectious complications in both untreated and treated chronic lymphocytic leukaemia. Landmark clinical trials involving the contemporary chronic lymphocytic leukaemia chemo- and immunotherapies, alone or in combination, as well as the main epidemiological studies establishing the increased rate of second cancers in chronic lymphocytic leukaemi...Keywords
This publication has 58 references indexed in Scilit:
- The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemiaBlood, 2008
- From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunityAutoimmunity Reviews, 2007
- Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab – incidence and predictorsBritish Journal of Haematology, 2007
- Autoimmune Complications of Chronic Lymphocytic LeukemiaSeminars in Oncology, 2006
- Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma†American Journal of Hematology, 2003
- Abnormal T-cell Function in B-cell Chronic Lymphocytic LeukaemiaLeukemia & Lymphoma, 2003
- Malignant chronic lymphocytic leukemia B cells elaborate soluble factors that down‐regulate T cell and NK functionAmerican Journal of Hematology, 1989
- Clinical signification of natural killer activity in B‐cell chronic lymphocytic leukemiaEuropean Journal of Haematology, 1987
- Serum Immunoglobulins and Lymphocyte Subsets in Chronic Lymphocytic LeukemiaAmerican Journal of Clinical Pathology, 1987
- Abnormal T cell function in early‐stage chronic lymphocytic leukemia (CLL) patientsAmerican Journal of Hematology, 1986